Greetings! My name is Robert Musacchio; I am proud to introduce myself as the new Chief Executive Officer and Executive Vice President of CHEST. I am honored to join this team of distinguished clinicians as we spearhead progress in the fight against lung disease.
I have had the pleasure of working at CHEST for the last 4 years, first joining CHEST Enterprises as Senior Vice President of Business Development. In that role, I focused on revenue growth and product diversification before becoming COO of CHEST. As COO, I dedicated myself to strengthening our team by mentoring staff and collaborating with senior leadership, a challenge that I have deeply enjoyed.
Before joining CHEST, I worked at the American Medical Association for 35 years in roles encompassing research, advocacy, membership, and publishing. I also worked with boards and membership groups as a member of the AMA’s CPT® Editorial Panel and as a publisher for JAMA.
As CEO, I hope to leverage those experiences to support CHEST in its mission, which is to improve lung health not just for 1 year but for the next 25 years. For that reason, our leadership team has outlined an organizational culture that fosters short-term success and long-term innovation, focusing on four key areas:
People: How do we attract and retain the right people?
Strategy: How do we create a truly differentiated strategy?
Execution: How do we improve our process to drive flawless execution?
Resources: How do we ensure that we have sufficient resources to invest in our mission?
Those questions in mind, we have established several standards that guide the way we work. We are focusing on leading with integrity, cultivating passion and innovation, honoring our team, and having fun while we deliver cutting-edge education and create community for our members. With these norms, we can continue to foster an environment that generates results. This, in turn, will enable CHEST to fulfill its core purpose of crushing lung disease.
We can crush lung disease by arming our members with industry-leading education offerings—including simulation experiences and live lab courses—and expanding them worldwide to Thailand and Greece in 2019. We can crush lung disease by using cutting-edge technologies—including interactive gaming platforms—to glean further insights. We can crush lung disease by connecting our membership of nearly 20,000 pulmonary, critical care, and sleep medicine professionals to innovative education tools, along with a network of prestigious colleagues to deliver the highest quality patient care.
Most importantly, we can crush lung disease by empowering our members in their work—if you care about lung disease, we care about you!
And, if you care about lung disease, I am excited to partner with you in this cause. I am thankful for this opportunity to lead CHEST and the CHEST Foundation into the future and look forward to working with you.